TRIOCHEM PRODUCTS LTD.

Classified in the pharmaceuticals sector, the company reported nil revenue from operations in FY26 with total income of Rs 86.45 lakhs. The Board has acknowledged that post-Covid business impact continues, particularly affecting operations that require personal relationships, alongside a shrinking regular customer base. The company recorded a loss before exceptional items of Rs 64.85 lakhs in FY26, but reported a net profit of Rs 797.07 lakhs driven by an exceptional gain of Rs 1,116.65 lakhs from the sale of immovable properties and investment properties in Maharashtra, which had a written-down value of Rs 56.92 lakhs and were sold for approximately Rs 1,173.20 lakhs in cash. The company carries no outstanding loans or financial indebtedness, and operating cash flow was negative Rs 287.40 lakhs in FY26.